Yuping Tsai1, Fangjun Zhou2, Pascale Wortley3, Abigail Shefer4, Shannon Stokley2. 1. Carter Consulting, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, GA. Electronic address: ytsai@cdc.gov. 2. National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, GA. 3. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC), Atlanta, GA. 4. Center for Global Health, Global Immunization Division, Centers for Disease Control and Prevention (CDC), Atlanta, GA.
Abstract
OBJECTIVE: To examine preventive care visit patterns among commercially insured adolescents during 2003-2010. In 2005-2007, the Advisory Committee on Immunization Practices (ACIP) recommended 3 vaccines targeted at adolescents. We also investigate the relationship between preventive care visits and immunization. STUDY DESIGN: Data were drawn from the MarketScan database. Adolescents aged 11-21 continuously enrolled in the same insurance plan during the calendar year were included. We calculated the annual proportion of adolescents with at least 1 preventive and 1 vaccination-related visit. Longitudinal analyses were conducted by following the 1992 birth cohort for 8 consecutive years. RESULTS: The proportion of adolescents making at least 1 preventive visit increased from 24.6%-41.1% during 2003-2010. The rate of vaccination-related visits increased from 12.9%-26.3%. The magnitude of the increase in preventive and vaccination-related visits was greater during the years in which ACIP issued recommendations. The rates of preventive and vaccination-related visits were considerably higher among female and early adolescents and adolescents in managed care plans. Longitudinal analyses indicated that only 2.4% of adolescents had an annual preventive visit during the 8 years. CONCLUSIONS: Yearly improvements in preventive care visits by adolescents were substantial. ACIP recommendations may be associated with this improvement. However, ongoing efforts are needed to improve the use and delivery of preventive care services.
OBJECTIVE: To examine preventive care visit patterns among commercially insured adolescents during 2003-2010. In 2005-2007, the Advisory Committee on Immunization Practices (ACIP) recommended 3 vaccines targeted at adolescents. We also investigate the relationship between preventive care visits and immunization. STUDY DESIGN: Data were drawn from the MarketScan database. Adolescents aged 11-21 continuously enrolled in the same insurance plan during the calendar year were included. We calculated the annual proportion of adolescents with at least 1 preventive and 1 vaccination-related visit. Longitudinal analyses were conducted by following the 1992 birth cohort for 8 consecutive years. RESULTS: The proportion of adolescents making at least 1 preventive visit increased from 24.6%-41.1% during 2003-2010. The rate of vaccination-related visits increased from 12.9%-26.3%. The magnitude of the increase in preventive and vaccination-related visits was greater during the years in which ACIP issued recommendations. The rates of preventive and vaccination-related visits were considerably higher among female and early adolescents and adolescents in managed care plans. Longitudinal analyses indicated that only 2.4% of adolescents had an annual preventive visit during the 8 years. CONCLUSIONS: Yearly improvements in preventive care visits by adolescents were substantial. ACIP recommendations may be associated with this improvement. However, ongoing efforts are needed to improve the use and delivery of preventive care services.
Authors: Jonathan D Klein; Laura P Shone; Peter G Szilagyi; Alina Bajorska; Karen Wilson; Andrew W Dick Journal: Pediatrics Date: 2007-04 Impact factor: 7.124
Authors: Cynthia M Rand; Laura P Shone; Christina Albertin; Peggy Auinger; Jonathan D Klein; Peter G Szilagyi Journal: Arch Pediatr Adolesc Med Date: 2007-03
Authors: Karen R Broder; Margaret M Cortese; John K Iskander; Katrina Kretsinger; Barbara A Slade; Kristin H Brown; Christina M Mijalski; Tejpratap Tiwari; Emily J Weston; Amanda C Cohn; Pamela U Srivastava; John S Moran; Benjamin Schwartz; Trudy V Murphy Journal: MMWR Recomm Rep Date: 2006-03-24
Authors: Allison Kempe; Sean T O'Leary; Jo Ann Shoup; Shannon Stokley; Steven Lockhart; Anna Furniss; L Miriam Dickinson; Juliana Barnard; Matthew F Daley Journal: Pediatrics Date: 2016-02-26 Impact factor: 7.124
Authors: Cynthia A Bonville; Joseph B Domachowske; Donald A Cibula; Manika Suryadevara Journal: Hum Vaccin Immunother Date: 2017-10-13 Impact factor: 3.452
Authors: Mandy A Allison; Laura P Hurley; Lauri Markowitz; Lori A Crane; Michaela Brtnikova; Brenda L Beaty; Megan Snow; Janine Cory; Shannon Stokley; Jill Roark; Allison Kempe Journal: Pediatrics Date: 2016-01-04 Impact factor: 7.124
Authors: Parth D Shah; William A Calo; Macary W Marciniak; Melissa B Gilkey; Noel T Brewer Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-06-05 Impact factor: 4.254
Authors: Parth D Shah; Justin G Trogdon; Shelley D Golden; Carol E Golin; Macary Weck Marciniak; Noel T Brewer Journal: Milbank Q Date: 2018-09 Impact factor: 4.911